A compound in carrots may be a potent cancer fighter, reducing malignancies in rats by a third, a European study claims. "One of the natural pesticides in carrots is responsible for the cancer-preventing effect of carrots," said researcher Kirsten Brandt, a senior lecturer at the University of Newcastle upon Tyne, in England. "We now have identified a compound which seems to have an effect that can explain this benefit." Falcarinol, a compound that protects the vegetable from fungal diseases, may be the prime reason carrots are so unfriendly to cancers. One previous study had suggested that might be the case, but results were inconclusive.
Nutrition experts have long recommended that people eat carrots because of their apparent ability to prevent cancer (and help our eyesight too) Until now the particular compound that prevents cancer was unknown. Epidemiological studies have shown that individuals with the highest carrot consumption can lower their risk of cancer by up to 40 percent.
Now they did study this in rats with a type of colorectal cancer. If you contemplate eating more carrots in your diet, please mention it to your doctors to see what they say.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...